Translational Control of Dengue Viral Genome: - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

Translational Control of Dengue Viral Genome:

Description:

Dengue is one of the most important mosquito-born viral diseases affecting humans. ... Has the ability to replicate in mosquitoes and primate cells. The DEN Virus ... – PowerPoint PPT presentation

Number of Views:65
Avg rating:3.0/5.0
Slides: 24
Provided by: annamariac
Learn more at: http://oregonstate.edu
Category:

less

Transcript and Presenter's Notes

Title: Translational Control of Dengue Viral Genome:


1
Translational Control ofDengue Viral Genome
  • Role of 3 UTR CS1
  • Anna Carmona
  • Mentor Dr. Theo Dreher
  • Assisted Wei-Wei Chiu
  • Department of Microbiology, Oregon State
    University

2
About Dengue
  • Dengue is one of the most important mosquito-born
    viral diseases affecting humans.
  • Viral life cycle involves humans and the mosquito
    vector Aedes aegypti.
  • In the U.S. it has been found that the mosquito
    Aedes albopictus also transmits the DEN virus.
  • The disease is caused by 4 serotypes of the
    Dengue virus, a member of the genus Flavivirus
    DEN-1, DEN-2, DEN-3, DEN-4.
  • Infection with the DEN virus can result in Dengue
    Fever (DF), Dengue Hemorrhagic Fever (DHF) and
    Dengue Shock Syndrome (DSS).

3
DEN-2 Serotype
  • Strain 16681 from Thailand.
  • DEN virus is an enveloped, 10.75 kb, positive,
    single-stranded RNA virus.
  • 1 ORF, 380 kDa.
  • Structure contains a 5 cap and a 3 stem-loop
    structure (no 3 -poly(A) tail).
  • Has the ability to replicate in mosquitoes and
    primate cells.

4
The DEN Virus
  • The development of a vaccine
  • is a high priority with live attenuated virus as
    the preferred form.
  • A goal of this research is to restrict viral gene
    expression as a source of attenuation.
  • Risks for this include the possibility of
    attenuation reversal of a vaccine strain
    resulting in mutations that might increase gene
    expression.

5
Overall Goals of DEN Study
  • Translation efficiency of dengue viral gene
    expression.
  • Identify features in the 5 and 3 regions of
    DEN-2 RNA genome that control translation. This
    will be done using a sensitive luciferase
    reporter mRNA.
  • Determine whether the translation of DEN RNA is
    altered in the presence of viral proteins.
  • Understand the regulation of replication.

6
Overall Goals of DEN Study
  • Translation efficiency of dengue viral gene
    expression.
  • Identify features in the 5 and 3 regions of
    DEN-2 RNA genome that control translation. This
    will be done using a sensitive luciferase
    reporter mRNA.
  • Determine whether the translation of DEN RNA is
    altered in the presence of viral proteins.
  • Understand the regulation of replication.

7
Experimentation Series
8
Experimentation Series
  • 3 UTR ? Series

9
Experimentation Series
  • 3 UTR ? Series
  • CS1 Mutation Series

10
3 UTR ? SeriesLuciferase Constructs
Controls
? Constructs
11
CS1 Mutation Series
12
ExperimentalGeneral Design
LUC
2. In Vitro run-off Transcription by T7 RNA
Polymerase (with cap analog)
1. Linearize Plasmid
WWC WWC WWC
AC WWC AC AC
3. RNA Electroporation
Vero Monkey Kidney Cells
4. Cell Lysis
Lysate
5. Luciferase/Protein Assays
13
Luciferase Assay
  • When in the presence of the substrate LAR
    (Luciferase Assay Reagent), luciferase will
    undergo an enzymatic reaction that emits light.
  • This is measured in Relative Light Units (RLU).
  • Problem This assay does not take into account
    the total amount of cells that were lysed.

14
Protein Assay
  • The protein present in the lysates cause the
    Protein Assay Reagent to turn blue. Light
    absorbance at 595 nm is measured and used as a
    reflection on the total amount of protein present
    in the lysates.
  • Protein concentration is indicative of the
    lysates total cell number.
  • Results from the protein assay are measured in mg
    protein/µL of lysate. These values are then used
    to normalize the results from the Luciferase
    Assay (RLU/mg protein).

15
AnalysisLuciferase Expression
16
AnalysisFunctional ½ Life
Capped GCLGpolyA
1.0E10
10
8
8.0E09
RLU/mg protein
6
6.0E09
4
4.0E09
2
2.0E09
0
3
4
5
6
1
2
3
4
5
6
(hr)
1
2
T1/21.40 hr
Functional ½ Life shows the change over time of
the RNAs relative efficiency to be used as a
template for translation.
17
AnalysisAccumulative ½ Life
(x109)
Capped GCLGpolyA
1.0E10
10
8
8.0E09
RLU/mg protein
6
6.0E09
4
4.0E09
2
2.0E09
0
3
4
5
6
1
2
3
4
5
6
(hr)
1
2
T1/2 1.46 hr
c.f. T1/2 1.40 hr by rates
Accumulative ½ Life shows the amount of time it
takes for the mRNA to reach ½ of the maximum LUC
expression.
18
Results3 UTR ? Series
19
Results ½ Life Analysis
20
ResultsCS1 Mutation Series
21
Results½ Life Analysis
22
A Look Ahead
  • Cap/no cap 5 UTR ? series.
  • Examining cap dependent/independent translation.
  • Possible interactions between viral/cellular
    proteins and how they affect translation of DEN-2
    genome.

23
Acknowledgements
Dr. Dreher Wei-Wei Chiu Kevin Ahern HHMI NSF
Write a Comment
User Comments (0)
About PowerShow.com